Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2025-12-28 @ 1:36 AM
Study NCT ID:
NCT00740051
Status:
COMPLETED
Last Update Posted:
2014-06-27
First Post:
2008-08-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-08
Start Date Type:
None
Primary Completion Date:
2010-08
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2008-08-21
First Submit QC Date:
None
Study First Post Date:
2008-08-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-08-03
Results First Submit QC Date:
None
Results First Post Date:
2011-10-26
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-06-17
Last Update Post Date:
2014-06-27
Last Update Post Date Type:
ESTIMATED